Tickerplace logo

Tickerplace

BridgeBio Oncology Therapeutics Inc. logo

BBOTBridgeBio Oncology Therapeutics Inc.

BBOT Stock Price, Valuation & Chart | BridgeBio Oncology Therapeutics Inc.

Compare
$8.890+0.07 (+0.79%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyBBOT intrinsic valueBBOT calculated fair value vs price
OverviewFinancialsDividendsRatios

BBOT Historical price chart

BBOT Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization712.15M
PE Ratio-4.43
EPS-2.01
Trading Volume238.88K
Today's High/Low9.19/8.71
Dividend Yield0.00
52 Week High/Low14.87/7.0
Shares Outstanding80.11M
BBOT Financial Statement
BBOT Analyst ratings
BBOT Analysis & performance metrics

BBOT Company profile

BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies,…

BBOT Management team

Management
Bihua ChenCEO
Chairperson & Chief Executive Officer
Nebojsa Obradovic
Chief Legal Officer
Caleb Jonathan TrippCFO
Chief Financial Officer
Total 3 executives

BBOT Frequently asked questions

What is BridgeBio Oncology Therapeutics Inc. (BBOT) Stock Price?

Current stock price of BridgeBio Oncology Therapeutics Inc. (BBOT) stock is $8.890. The stock price is +0.79% higher in the session. The intraday range can be seen from this page. Volume of BridgeBio Oncology Therapeutics Inc. (BBOT) stock is 238.88K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the BridgeBio Oncology Therapeutics Inc. (BBOT) stock price going up or down today?

The stock price of BridgeBio Oncology Therapeutics Inc. (BBOT) can change with earnings, company news, and overall market sentiment. BridgeBio Oncology Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BridgeBio Oncology Therapeutics Inc. stock expensive at its current price?

Whether BridgeBio Oncology Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BBOT on this page is -4.43. EPS on this page is -2.01. Compare those figures with peers and growth expectations before deciding if the current BridgeBio Oncology Therapeutics Inc. price is justified.

How has the stock price of BridgeBio Oncology Therapeutics Inc. (BBOT) performed historically?

Historical performance for BridgeBio Oncology Therapeutics Inc. (BBOT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BBOT reacted to past earnings and market events.

Should I buy BridgeBio Oncology Therapeutics Inc. (BBOT) stock, at this price?

Buying BridgeBio Oncology Therapeutics Inc. (BBOT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.